Home  >  News
you can get e-magazine links on WhatsApp.Click here
+ Font Resize -

Abbott launches Jot Dx insertable cardiac monitor in US market to detect abnormal heart rhythms

Abbott Park, Illinois
Saturday, July 31, 2021, 11:00 Hrs  [IST]

Abbott announced the US launch of Jot Dx, the company’s latest insertable cardiac monitor (ICM). The Jot Dx ICM gives clinicians and hospitals control of how they manage the flow of information through a unique feature to view either all abnormal heart rhythm data or to simplify which irregular heart rhythms are recorded with a key episodes option. This technology allows for remote detection and improved diagnosis accuracy of cardiac arrythmia in patients. Jot Dx ICM is supported by SyncUP, a personalized service that delivers one-on-one training and education to help patients get connected and stay connected to their ICM.

An arrhythmia is an abnormal heart rhythm that develops when disease or injury disrupts the heart's electrical signals, causing the heart to beat erratically. As a result, arrhythmias can lead to symptoms such as palpitations, dizziness, and shortness of breath or fainting. The most common arrhythmia is atrial fibrillation, or AFib, which is projected to impact more than half of the worldwide population by 2050.

“Over the past year, there has been an increased focus on telehealth and connected care technology. This has provided access to more data, adding to the time needed to assess patients thoroughly,” said John Costello, D.O., Electrophysiology at The Heart House, Marlton, New Jersey. “With the Jot Dx key episodes option, the ability to distil information is a distinct, time-saving enhancement that helps care teams make important, life-saving clinical care decisions faster.”

In addition to improving workflow for physicians, clinics and health systems monitoring patients with potential abnormal heart rhythms, Abbott is also improving how patients interact with their device. A key element in the setup of Jot Dx ICM and the myMerlin mobile app is the new SyncUP support service, which Abbott offers on select products as part of its connected care portfolio. With SyncUP, an Abbott support expert will enroll a patient with a newly implanted device in the system, orient them through getting to know their new heart monitoring device and confirm connection to the myMerlin app.

SyncUP is designed to educate people about the technology from the comfort of home, which has been shown to increase information retention and encourage compliance4, and helps reduce in-clinic burden. Currently, the process to ensure a patient is connected is conducted in the healthcare facility directly following the device’s implant, which prolongs the stay for the patient.

“Technology can be intimidating, particularly when your heart is relying on it,” said Heidi Hinrichs, divisional vice president of global clinical and regulatory for Abbott's Cardiac Rhythm Management business. “With Jot Dx ICM, myMerlin, SyncUP and our other technologies, we want people to feel supported, knowledgeable and confident when using them, and ultimately, in control of their care. We understand healthcare is not one-size-fits-all and have learned from the people who use our products that a patient-centric approach can lead to a more manageable heart health experience.”

The myMerlin mobile app collects information from a patient’s heart device and sends it to their healthcare team. The app allows patients to engage more frequently with their healthcare team by providing access to transmission history and device performance, and the app can prompt patients to schedule their next appointment.


Post Your commentsPOST YOUR COMMENT
* Name :     
* Email :    
  Website :  
Copyright © 2016 Saffron Media Pvt. Ltd |